ICR Healthcare Conference Series 

ICR Healthcare ADC Webinar
Developing the Next Generation of Innovations in Antibody-Drug Conjugates (ADCs)

The link to join the Live Event will be visible here 10 minutes prior to event start. Please refresh your screen if it does not appear.

Wednesday, September 30, 2026 | 11:00 AM - 12:00 PM ET | 4:00 PM - 5:00 PM BST | 5:00 PM - 6:00 PM CET

The next installment of the ICR Healthcare Conference Series will focus on the evolving development of treatments for Antibody-Drug Conjugates.

Discussion topics will include:

  • The giant leaps in innovation being made in the field and how they will impact the market
  • How ADC therapies are overcoming the challenges of the past
  • Assessing Big Pharma's appetite for the field
  • Looking 10 years ahead: The future landscape of ADC therapies

SPEAKERS  - Click name for bio 

Edward Tenthoff

Piper Sandler
Sr Research Analyst

Christoph Antz, Ph.D.

VERAXA Biotech AG
Chief Executive Officer and Co-Founder

Jack Elands

Adcytherix
Founder and Chief Executive Officer

Zachary Hornby

Callio Therapeutics
Chief Executive Officer

Christoph Korpus PhD, MBA

Byondis B.V.
Chief Executive Officer